Checked.be
Active
BE 0737.829.015Public limited company
CELYNTRA THERAPEUTICS
Rue Edouard Belin 2 ·1435 Mont-Saint-Guibert, Belgium· 6 yrs active
Sector: Groothandel in farmaceutische en medische artikelen
(46460)
Conclusion
The computed 12-month bankruptcy probability of CELYNTRA THERAPEUTICS is 1.3% (low). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Key figures
| Active | 6 yrs |
| Board | 1 |
| Locations | 1 |
| Publications | 7 |
Bankruptcy probability (12 mo)
1.3%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-risk legal form
−Higher-failure-rate sector
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2019, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview
Financials being processed
NBB has 7 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | volledig | 10-06-2026 | 2026-00150073 |
| 31-12-2024 | volledig | 16-10-2025 | 2025-00543890 |
| 31-12-2023 | volledig | 24-07-2024 | 2024-00293670 |
| 31-12-2022 | volledig | 30-06-2023 | 2023-00179017 |
| 31-12-2021 | volledig | 23-09-2022 | 2022-20436329 |
| 31-12-2020 | volledig | 30-09-2021 | 2021-69300251 |
| 31-12-2019 | volledig | 30-07-2020 | 2020-36800014 |
Directors & mandates
Current directors & mandates
-
Current05-03-2026 → present
Former directors (2)
-
Former07-06-2024 → 05-03-2026
2 events
- 05-03-2026 Resigned· Director
- 07-06-2024 Appointed· Director
-
Former- → 07-06-2024
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| PwC Réviseurs d'Entreprises SRLCurrent Statutory auditor · represented by Romain Seffer |
- | 21-06-2022 → present |
Show 1 earlier auditors
| BDO Réviseurs d'Entreprises SRL Statutory auditor · represented by Gert Claes |
- | - → 01-01-2022 |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 19-11-2019 |
| Status | Active |
| Postal code | 1435 |
Connections & network
Network connections
Shared address
→
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Establishment units
CELYNTRA THERAPEUTICS
since 20192.299.080.043
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2026
12-06-2026
State Gazette act
Open capture
10-06-2026
NBB filing
Annual accounts filed
07-05-2026
State Gazette act
Open capture
2025
16-10-2025
NBB filing
Annual accounts filed
2024
26-08-2024
State Gazette act
Director changes
24-07-2024
NBB filing
Annual accounts filed
2023
20-09-2023
State Gazette act
Capital & shares
30-06-2023
NBB filing
Annual accounts filed
31-03-2023
State Gazette act
Registered-office change
2022
23-09-2022
NBB filing
Annual accounts filed
21-06-2022
State Gazette act
Director changes
2021
30-09-2021
NBB filing
Annual accounts filed
2020
30-07-2020
NBB filing
Annual accounts filed
2019
21-11-2019
State Gazette act
Incorporation
Belgian State Gazette reading coverage
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Belgisch Staatsblad, acts
Capital history · 1
20-09-2023
v3.2
Address history · 1
31-03-2023
v3.2
All acts · 7
updated 2 months ago
2026
12-06-2026 Auditor mandate · Permanent representative · Mandate term · Power of attorney
- Filing: 2026-06-02 · Celyntra Therapeutics
- Auditor mandate: term: trois ans, end_date: 2027-12-31, start_date: 2026-03-05 · Celyntra Therapeutics
- Permanent representative: role: représentant · PwCReviseurs d'Entreprises SRL
- Mandate term: end_date: 2027-12-31 · PwCReviseurs d'Entreprises SRL
- Power of attorney: date: 2026-03-05, scope: publication des résolutions · Celyntra Therapeutics
- Power of attorney: date: 2026-03-05, scope: publication des résolutions · Celyntra Therapeutics
- Power of attorney: date: 2026-03-05, scope: publication des résolutions · Celyntra Therapeutics
- Power of attorney: date: 2026-03-05, scope: publication des résolutions · Celyntra Therapeutics
- Publication: 2026-06-12
- Act object: Renouvellement mandat commissaire - Pouvoirs spéciaux
Summary:
Auditor mandate · Permanent representative · Mandate term · Power of attorney
Technical details
{
"facts": [
{
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE 02 JUIN 2026",
"value": "2026-06-02",
"object": null,
"subject": "e1"
},
{
"type": "auditor_mandate",
"quote": "L\u0027Actionnaire d\u00E9cide de renommer PwCReviseurs d\u0027Entreprises SRL, ayant son si\u00E8ge\u00E0 1831 Diegem, Culliganlaan 5, commecommissaire pour un terme de trois ans.",
"value": {
"term": "trois ans",
"end_date": "2027-12-31",
"start_date": "2026-03-05"
},
"object": "e2",
"subject": "e1"
},
{
"type": "permanent_representative",
"quote": "PwCReviseurs d\u0027Entreprises SRL d\u00E9signe M.Romain Seffer, r\u00E9viseur d\u0027entreprises, pour larepr\u00E9senter et le charge de l\u0027exercice de cemandat au nom et pour le compte de PwCReviseurs d\u0027Entreprises SRL.",
"value": {
"role": "repr\u00E9sentant"
},
"object": "e3",
"subject": "e2"
},
{
"type": "mandate_term",
"quote": "Son mandatprendra fin \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9raleannuelle des actionnaires appel\u00E9e \u00E0 statuersur les comptes annuels de l\u0027exercice socialqui sera cl\u00F4tur\u00E9 le 31 d\u00E9cembre 2027.",
"value": {
"end_date": "2027-12-31"
},
"object": null,
"subject": "e2"
},
{
"type": "power_of_attorney",
"quote": "L\u0027Actionnaire donne procuration, avec facult\u00E9 de substitution, \u00E0 Mr. C\u00E9dric Darcis, conseil juridique de la Soci\u00E9t\u00E9, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9",
"value": {
"date": "2026-03-05",
"scope": "publication des r\u00E9solutions",
"substitution": true
},
"object": "e4",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "Mme Nathalie Locht et/ou M. Timothy Speelman et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles, Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le compte de la Soci\u00E9t\u00E9, toute d\u00E9marche et de signer tout document n\u00E9cessaire \u00E0 la publication des r\u00E9solutions qui pr\u00E9c\u00E8dent aux Annexes du Moniteur belge et de faire toute d\u00E9marche utile ou n\u00E9cessaire y aff\u00E9rente.",
"value": {
"date": "2026-03-05",
"scope": "publication des r\u00E9solutions",
"substitution": true
},
"object": "e5",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "Mme Nathalie Locht et/ou M. Timothy Speelman et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles, Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le compte de la Soci\u00E9t\u00E9, toute d\u00E9marche et de signer tout document n\u00E9cessaire \u00E0 la publication des r\u00E9solutions qui pr\u00E9c\u00E8dent aux Annexes du Moniteur belge et de faire toute d\u00E9marche utile ou n\u00E9cessaire y aff\u00E9rente.",
"value": {
"date": "2026-03-05",
"scope": "publication des r\u00E9solutions",
"substitution": true
},
"object": "e6",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "Mme Nathalie Locht et/ou M. Timothy Speelman et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles, Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le compte de la Soci\u00E9t\u00E9, toute d\u00E9marche et de signer tout document n\u00E9cessaire \u00E0 la publication des r\u00E9solutions qui pr\u00E9c\u00E8dent aux Annexes du Moniteur belge et de faire toute d\u00E9marche utile ou n\u00E9cessaire y aff\u00E9rente.",
"value": {
"date": "2026-03-05",
"scope": "publication des r\u00E9solutions",
"substitution": true
},
"object": "e7",
"subject": "e1"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 12/06/2026",
"value": "2026-06-12",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte : Renouvellement mandat commissaire - Pouvoirs sp\u00E9ciaux",
"value": "Renouvellement mandat commissaire - Pouvoirs sp\u00E9ciaux",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 2051,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0737.829.015",
"kind": "company",
"name": "Celyntra Therapeutics",
"attrs": {
"seat": "Rue Edouard Belin 2, 1435 Mont-Saint-Guibert",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "org",
"name": "PwCReviseurs d\u0027Entreprises SRL",
"attrs": {
"seat": "1831 Diegem, Culliganlaan 5"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Romain Seffer",
"attrs": {
"role": "r\u00E9viseur d\u0027entreprises"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "C\u00E9dric Darcis",
"attrs": {
"role": "conseil juridique de la Soci\u00E9t\u00E9"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Nathalie Locht",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Timothy Speelman",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Pieter De Vos",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "org",
"name": "AKD SRL",
"attrs": {
"seat": "place du Champ de Mars 5, 1050 Ixelles, Belgique"
}
}
]
}07-05-2026 Officer resignation · Officer appointment · Mandate term · Mandate compensation
- Filing: 2026-04-24 · Celyntra Therapeutics
- Publication: 2026-05-07 · Celyntra Therapeutics
- Officer resignation: role: administrateur, effective_date: 2026-03-05 · Gustavo Mahler
- Officer appointment: role: administrateur unique, domicile: siège de la Société, effective_date: 2026-03-05 · Jason Conner
- Mandate term: role: administrateur unique, duration: six ans · Jason Conner
- Mandate compensation: role: administrateur, compensation: non rémunéré · Jason Conner
- Power of attorney: date: 2026-03-05, purpose: publication des résolutions aux Annexes du Moniteur belge, granted_by: Actionnaire unique, joint_or_several: ensemble ou séparément · Celyntra Therapeutics
- Power of attorney: date: 2026-03-05, purpose: publication des résolutions aux Annexes du Moniteur belge, granted_by: Actionnaire unique, joint_or_several: ensemble ou séparément · Celyntra Therapeutics
- Power of attorney: date: 2026-03-05, purpose: publication des résolutions aux Annexes du Moniteur belge, granted_by: Actionnaire unique, joint_or_several: ensemble ou séparément · Celyntra Therapeutics
- Act object: Démission - Nomination - Pouvoirs spéciaux
Summary:
Officer resignation · Officer appointment · Mandate term · Mandate compensation
Technical details
{
"facts": [
{
"type": "filing",
"quote": "TRIBUNAL DE L\u0027ENTREPRISE 24 AVR. 2026",
"value": "2026-04-24",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 07/05/2026 - Annexes du Moniteur belge",
"value": "2026-05-07",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "Il r\u00E9sulte des r\u00E9solutions \u00E9crites de l\u0027actionnaire unique du 5 mars 2026 que: 1. L\u0027Actionnaire accepte et confirme, pour autant que de besoin, la d\u00E9mission de M. Gustavo Mahler en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat.",
"value": {
"role": "administrateur",
"effective_date": "2026-03-05"
},
"object": "e1",
"subject": "e2"
},
{
"type": "officer_appointment",
"quote": "2. L\u0027Actionnaire nomme M. Jason Conner, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9 pour les besoins de son mandat, comme administrateur unique de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat pour une dur\u00E9e de six ans.",
"value": {
"role": "administrateur unique",
"domicile": "si\u00E8ge de la Soci\u00E9t\u00E9",
"effective_date": "2026-03-05"
},
"object": "e1",
"subject": "e3"
},
{
"type": "mandate_term",
"quote": "comme administrateur unique de la Soci\u00E9t\u00E9 avec effet imm\u00E9diat pour une dur\u00E9e de six ans.",
"value": {
"role": "administrateur unique",
"duration": "six ans"
},
"object": "e1",
"subject": "e3"
},
{
"type": "mandate_compensation",
"quote": "Le mandat de M. Jason Conner en tant qu\u0027administrateur n\u0027est pas r\u00E9mun\u00E9r\u00E9.",
"value": {
"role": "administrateur",
"compensation": "non r\u00E9mun\u00E9r\u00E9"
},
"object": "e1",
"subject": "e3"
},
{
"type": "power_of_attorney",
"quote": "4. L\u0027Actionnaire donne procuration, avec facult\u00E9 de substitution, \u00E0 M. Timothy Speelman, Mile. Charlotte Vanham et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles. Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le compte de la Soci\u00E9t\u00E9, toute d\u00E9marche et de signer tout document ou d\u00E9clarations n\u00E9cessaires \u00E0 la publication des r\u00E9solutions qui pr\u00E9c\u00E8dent aux Annexes du Moniteur belge et de faire toute d\u00E9marche utile ou n\u00E9cessaire y aff\u00E9rente.",
"value": {
"date": "2026-03-05",
"purpose": "publication des r\u00E9solutions aux Annexes du Moniteur belge",
"granted_by": "Actionnaire unique",
"substitution": true,
"joint_or_several": "ensemble ou s\u00E9par\u00E9ment"
},
"object": "e4",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "4. L\u0027Actionnaire donne procuration, avec facult\u00E9 de substitution, \u00E0 M. Timothy Speelman, Mile. Charlotte Vanham et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles. Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le compte de la Soci\u00E9t\u00E9, toute d\u00E9marche et de signer tout document ou d\u00E9clarations n\u00E9cessaires \u00E0 la publication des r\u00E9solutions qui pr\u00E9c\u00E8dent aux Annexes du Moniteur belge et de faire toute d\u00E9marche utile ou n\u00E9cessaire y aff\u00E9rente.",
"value": {
"date": "2026-03-05",
"purpose": "publication des r\u00E9solutions aux Annexes du Moniteur belge",
"granted_by": "Actionnaire unique",
"substitution": true,
"joint_or_several": "ensemble ou s\u00E9par\u00E9ment"
},
"object": "e5",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "4. L\u0027Actionnaire donne procuration, avec facult\u00E9 de substitution, \u00E0 M. Timothy Speelman, Mile. Charlotte Vanham et/ou M. Pieter De Vos, \u00E9lisant domicile chez AKD SRL, place du Champ de Mars 5, 1050 Ixelles. Belgique, avec pouvoir d\u0027agir ensemble ou s\u00E9par\u00E9ment, aux fins d\u0027effectuer, au nom et pour le compte de la Soci\u00E9t\u00E9, toute d\u00E9marche et de signer tout document ou d\u00E9clarations n\u00E9cessaires \u00E0 la publication des r\u00E9solutions qui pr\u00E9c\u00E8dent aux Annexes du Moniteur belge et de faire toute d\u00E9marche utile ou n\u00E9cessaire y aff\u00E9rente.",
"value": {
"date": "2026-03-05",
"purpose": "publication des r\u00E9solutions aux Annexes du Moniteur belge",
"granted_by": "Actionnaire unique",
"substitution": true,
"joint_or_several": "ensemble ou s\u00E9par\u00E9ment"
},
"object": "e6",
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: D\u00E9mission - Nomination - Pouvoirs sp\u00E9ciaux",
"value": "D\u00E9mission - Nomination - Pouvoirs sp\u00E9ciaux",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 2266,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0737.829.015",
"kind": "company",
"name": "Celyntra Therapeutics",
"attrs": {
"seat": "Rue Edouard Belin 2, 1435 Mont-Saint-Guibert",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Gustavo Mahler",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Jason Conner",
"attrs": {}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Timothy Speelman",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Charlotte Vanham",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Pieter De Vos",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "org",
"name": "AKD SRL",
"attrs": {
"address": "place du Champ de Mars 5, 1050 Ixelles, Belgique"
}
}
]
}2024
26-08-2024 1 director appointed, 1 resigning
- Gustavo Mahler, Bestuurder
- Stefan Braam, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Stefan Braam",
"address": null,
"birth_date": null
},
"effective_date": "2024-06-07",
"evidence_quote": "La d\u00E9mission de M. Stefan Braam en tant qu\u0027administrateur unique de la soci\u00E9t\u00E9 avec effet au 7 juin 2024 est, pour autant que de besoirn, accept\u00E9e et confirm\u00E9e."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Gustavo Mahler",
"address": null,
"birth_date": null
},
"effective_date": "2024-06-07",
"evidence_quote": "L\u0027actionnaire nomme M. Gustavo Mahler, \u00E9lisar\u0131t domicile au si\u00E8ge de la soci\u00E9t\u00E9 pour les besoins de sori mandat, en tant qu\u0027administrateur unique de la soci\u00E9t\u00E9 pour une dur\u00E9e ind\u00E9termin\u00E9e \u00E0 compter du 7 juin 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}2023
20-09-2023 Capital increase of €2,100,000 to €2,161,500
- €61.500 → €2.161.500
- 2 kapitaalbewegingen in deze akte
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 2100000.0,
"currency": "EUR",
"after_eur": 2161500.0,
"delta_eur": 2100000.0,
"before_eur": 61500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-09-04",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u2019augmenter le capital par un apport en num\u00E9raire d\u0027un montant de deux millions cent mille euros (\u20AC 2.100.000,00) pour porter le capital de soixante et un mille cinq cents euros (\u20AC 61.500,00) \u00E0 deux millions cent soixante et un mille cinq cents euros (\u20AC 2.161.500,00) sans cr\u00E9ation de nouvelles actions.",
"contribution_type": "cash"
},
{
"kind": "capital_decrease",
"amount": 1809200.0,
"currency": "EUR",
"after_eur": 352300.0,
"delta_eur": -1809200.0,
"before_eur": 2161500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-09-04",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire formellement le capital \u00E0 concurrence d\u2019un million huit cent neuf mille deux cents euros (\u20AC 1.809.200,00), pour ramener le capital de deux millions cent soixante et un mille cinq cents euros (\u20AC 2.161.500,00) \u00E0 trois cent cinquante-deux mille trois cents euros (\u20AC 352.300,00), par l\u0027absorption des pertes subies",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}31-03-2023 Registered office moved from Gosselies to Mort-Saint-Guibert
- rue Adrienne Bolland 47, 6041 Gosselies → rue Edouard Belin 2, 1435 Mort-Saint-Guibert
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Mort-Saint-Guibert",
"region": null,
"street": "rue Edouard Belin",
"country": "BE",
"postcode": "1435",
"box_number": null,
"street_number": "2"
},
"old_address": {
"city": "Gosselies",
"region": null,
"street": "rue Adrienne Bolland",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "47"
},
"effective_date": "2023-03-01",
"evidence_quote": "L\u0027administrateur d\u00E9cide de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 de 6041 Gosselies, rue Adrienne Bolland 47 \u00E0 1435 Mort-Saint-Guibert, rue Edouard Belin 2 \u00E0 partir du 1er mars 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}2022
21-06-2022 1 director appointed, 1 resigning
- Romain Seffer, Commissaris
- Gert Claes, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Gert Claes",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BDO Reviseurs d\u0027Entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-01-01",
"evidence_quote": "L\u0027administrateur a pris note du fait que BDO Reviseurs d\u0027Entreprises SRL, le commissaire de la soci\u00E9t\u00E9, a d\u00E9cid\u00E9 de remplacer No\u00EBlle Lucas en tant que repr\u00E9sentant l\u00E9gal par Gert Claes \u00E0 partir du 1 janvier 2022"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Romain Seffer",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "PwC Reviseurs d\u0027Entreprises SRL",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027actionnaire a d\u00E9cid\u00E9 de nommer PwC Reviseurs d\u0027Entreprises SRL, ayant son si\u00E8ge \u00E0 1831 Diegem, Culliganlaan 5, comme commissaire pour un terme de trois ans. PwC Reviseurs d\u0027Entreprises SRL a d\u00E9sign\u00E9 M. Romain Seffer, r\u00E9viseur d\u0027entreprises, pour la repr\u00E9senter et le charge de l\u0027exercice de ce mand"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SA"
}
}2019
21-11-2019 Incorporation of a new SNC
Summary:
oprichting
Technical details
{
"kind": "oprichting",
"seat": "6041 Gosselies, Rue Adrienne Bolland 47",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0565.979.162",
"name": "Ncardia Holding"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0565.979.162",
"holder_org_name": "Ncardia Holding",
"contribution_type": "cash",
"amount_paid_in_eur": 61500.0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 100,
"amount_subscribed_eur": 61500.0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 61500.0,
"subject_company": {
"kbo": "0737.829.015",
"name_full": "CELYNTRA THERAPEUTICS",
"legal_form": "SNC"
},
"initial_directors": [],
"incorporation_date": "2019-11-07",
"post_incorporation_mandates": []
}Credit advice
Company registry (CBE)
Activities
Groothandel in farmaceutische en medische artikelen46460
Primary activity highlighted.
Names & trade names
| Legal nameFR | CELYNTRA THERAPEUTICS |
Registered office
Rue Edouard Belin 2
1435 Mont-Saint-Guibert, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
APIX
BE 0755.327.023 · Mont-Saint-Guibert
BESCAN
BE 0650.630.567 · Mont-Saint-Guibert
COLE PHARMACEUTICALS
BE 0671.904.152 · Mont-Saint-Guibert
LOUPI MEDICAL BELGIUM
BE 0799.500.625 · Mont-Saint-Guibert
PUGH & CO INTERNATIONAL
BE 0403.086.171 · Mont-Saint-Guibert